BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16788156)

  • 1. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
    J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
    Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kr├╝ppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
    Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
    Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.
    Bennett WP; el-Deiry WS; Rush WL; Guinee DG; Freedman AN; Caporaso NE; Welsh JA; Jones RT; Borkowski A; Travis WD; Fleming MV; Trastek V; Pairolero PC; Tazelaar HD; Midthun D; Jett JR; Liotta LA; Harris CC
    Clin Cancer Res; 1998 Jun; 4(6):1499-506. PubMed ID: 9626468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
    Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
    Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
    Komiya T; Hosono Y; Hirashima T; Masuda N; Yasumitsu T; Nakagawa K; Kikui M; Ohno A; Fukuoka M; Kawase I
    Clin Cancer Res; 1997 Oct; 3(10):1831-5. PubMed ID: 9815570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.
    Qiao H; Hung W; Tremblay E; Wojcik J; Gui J; Ho J; Klassen J; Campling B; Elliott B
    J Cell Biochem; 2002; 86(4):665-77. PubMed ID: 12210733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
    Bellotti M; Elsner B; Paez De Lima A; Esteva H; Marchevsky AM
    Mod Pathol; 1997 Dec; 10(12):1221-7. PubMed ID: 9436967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of CD151 gene expression in non-small cell lung cancer.
    Tokuhara T; Hasegawa H; Hattori N; Ishida H; Taki T; Tachibana S; Sasaki S; Miyake M
    Clin Cancer Res; 2001 Dec; 7(12):4109-14. PubMed ID: 11751509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
    Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
    Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinoma.
    Huang CI; Neuberg D; Johnson BE; Wei JY; Christiani DC
    Cancer; 2003 Jul; 98(1):135-43. PubMed ID: 12833466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
    Nishio M; Koshikawa T; Yatabe Y; Kuroishi T; Suyama M; Nagatake M; Sugiura T; Ariyoshi Y; Mitsudomi T; Takahashi T
    Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.
    Hsu NY; Ho HC; Chow KC; Lin TY; Shih CS; Wang LS; Tsai CM
    Cancer Res; 2001 Mar; 61(6):2727-31. PubMed ID: 11289154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS; Kong G; Sun S; Liu D; El-Naggar AK; Khuri FR; Hong WK; Lee HY
    Clin Cancer Res; 2002 Dec; 8(12):3796-802. PubMed ID: 12473592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of cables protein expression in human non-small cell lung cancer: a tissue microarray study.
    Tan D; Kirley S; Li Q; Ramnath N; Slocum HK; Brooks JS; Wu CL; Zukerberg LR
    Hum Pathol; 2003 Feb; 34(2):143-9. PubMed ID: 12612882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
    Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
    Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
    Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
    Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANTES expression is a predictor of survival in stage I lung adenocarcinoma.
    Moran CJ; Arenberg DA; Huang CC; Giordano TJ; Thomas DG; Misek DE; Chen G; Iannettoni MD; Orringer MB; Hanash S; Beer DG
    Clin Cancer Res; 2002 Dec; 8(12):3803-12. PubMed ID: 12473593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.